Healthy demand for revenue management solutions across various industries leads to top-line expansion for Model N (MODN) in the second quarter of fiscal 2024.
New Medicare Part D inflation rebate enhancement helps pharma manufacturers manage pricing reformsSAN MATEO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Model N (NYSE: MODN), the leader in revenue optimization and compliance has introduced a critical product enhancement that supports evolving compliance needs around the Inflation Reduction Act (IRA). The company has introduced a new Medicare Part D inflation rebate-per-unit, ensuring pharma manufacturers remain compliant with impending IRA regulati
Financial Highlights and Analyst Comparison for Q2 FY2024